We are live on ! Find out more
CNTA

Centessa Pharmaceuticals
CNTA

Delisted

CNTA was delisted on the 23rd of June, 2026.

Back to rankings

40 hedge funds and large institutions have $947M invested in Centessa Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 13 increasing their positions, 14 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

9.08% more ownership

Funds ownership: 54.23% → 63.31% (+9.1%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

7% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 14

9% less capital invested

Capital invested by funds: $1.05B → $947M (-$97.9M)

20% less funds holding

Funds holding: 50 → 40 (-10)

63% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 16

Holders
40
Holders Change
-10
Holders Change %
-20%
% of All Funds
0.7%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
6
Increased
13
Reduced
14
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
GA
General Atlantic
New York
+$169M
2
RCM
RA Capital Management
Massachusetts
+$47.5M
3
BBA
Baker Bros. Advisors
New York
+$15.1M
4
BC
Boxer Capital
California
+$8.9M
5
CAM
Cormorant Asset Management
Massachusetts
+$6.21M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$24.6M
2
ACA
Avoro Capital Advisors
New York
-$11.1M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$8.84M
4
Millennium Management
Millennium Management
New York
-$4.38M
5
MIM
Monashee Investment Management
Massachusetts
-$2.89M
Name Holding Trade Value Shares
Change 		Change in
Stake
TD Asset Management
26
TD Asset Management
Ontario, Canada
$555K – – –
BC
27
Brookfield Corp
Ontario, Canada
$447K +$174K +8,384 +46%
GCM
28
Ghisallo Capital Management
Massachusetts
$251K -$207K -10,000 -40%
D.E. Shaw & Co
29
D.E. Shaw & Co
New York
$207K +$257K +12,420 New
Morgan Stanley
30
Morgan Stanley
New York
$128K +$158K +7,630 New
Bank of America
31
Bank of America
North Carolina
$46K +$8.3K +401 +17%
CLOS
32
Compagnie Lombard Odier SCmA
Switzerland
$46K +$56.9K +2,750 New
JP Morgan Chase
33
JP Morgan Chase
New York
$30K -$5.42K -262 -13%
Royal Bank of Canada
34
Royal Bank of Canada
Ontario, Canada
$8K +$9.38K +453 New
UBS Group
35
UBS Group
Switzerland
$4K -$9.46K -457 -67%
Citigroup
36
Citigroup
New York
$3K -$18.3K -882 -81%
CSS
37
Cubist Systematic Strategies
Connecticut
$3K -$4.14K -200 -50%
EWA
38
Evolution Wealth Advisors
Florida
$3K +$3.31K +160 New
TRCT
39
Tower Research Capital (TRC)
New York
$2K -$19.8K -958 -89%
Wellington Management Group
40
Wellington Management Group
Massachusetts
– -$24.6M -1,106,577 Closed
ACA
41
Avoro Capital Advisors
New York
– -$11.1M -500,000 Closed
MIM
42
Monashee Investment Management
Massachusetts
– -$2.89M -130,000 Closed
State of Wisconsin Investment Board
43
State of Wisconsin Investment Board
Wisconsin
– -$1.78M -80,381 Closed
BI
44
BVF Inc
California
– -$1.31M -58,900 Closed
Tudor Investment Corp
45
Tudor Investment Corp
Connecticut
– -$957K -43,079 Closed
Temasek Holdings
46
Temasek Holdings
Singapore
– -$926K -41,680 Closed
Blackstone Inc
47
Blackstone Inc
New York
– -$888K -40,000 Closed
Squarepoint
48
Squarepoint
New York
– -$839K -37,771 Closed
MWNA
49
Marshall Wace North America
New York
– -$760K -34,228 Closed
Northern Trust
50
Northern Trust
Illinois
– -$409K -18,400 Closed
1
2
3

CNTA Hedge Fund Activity: Q3 2021 in Review

40 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Centessa Pharmaceuticals (CNTA) for Q3 2021, worth a combined $947M — down 9.4% from $1.05B a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of CNTA and 6 opened new positions — a net loss of 10 holders — while 14 trimmed existing stakes and 13 added.

The largest buyer was General Atlantic, adding an estimated $169M. The largest seller was Wellington Management Group, exiting entirely with an estimated $24.6M sold.

  • 40 institutional investors held Centessa Pharmaceuticals (CNTA) as of Q3 2021, down from 50 in Q2 2021.
  • Funds reported $947M of Centessa Pharmaceuticals stock for Q3 2021, down 9.4% quarter-over-quarter.
  • 6 funds opened new Centessa Pharmaceuticals positions in Q3 2021 and 16 closed out, a net change of -10 holders.
  • The largest Centessa Pharmaceuticals buyer in Q3 2021 was General Atlantic, an estimated $169M added.
  • The largest Centessa Pharmaceuticals seller in Q3 2021 was Wellington Management Group, an estimated $24.6M sold.

Based on aggregated 13F filings for Q3 2021.